| Literature DB >> 35524242 |
Qiang Huang1, YiBo Xu1, HanZhong Xue1, Qian Wang1, Ming Li1, Cheng Ren1, Yao Lu1, Zhong Li1, Kun Zhang2, Teng Ma3.
Abstract
BACKGROUND: The reduction in irreducible extracapsular hip fractures has always been controversial. Here, we present a new minimally invasive reduction technique and compare it with limited open reduction (LOR) to treat irreducible extracapsular hip fractures.Entities:
Keywords: Extracapsular hip fracture; Irreducible; Percutaneous reduction; Screwdriver
Mesh:
Year: 2022 PMID: 35524242 PMCID: PMC9077818 DOI: 10.1186/s12891-022-05390-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.562
Fig. 1A 63-year-old female suffered from an extracapsular hip fracture and was reduced by the PRDS technique. a and b After repeated closed reduction, the fracture fragments were still dislocated obviously; c-f: Under fluoroscopic guidance, the minimally invasive PRDS technique was performed; g Schematic diagram of the PRDS technique; h Sketch of incisions. PRDS stands for percutaneous reduction with double screwdrivers
Fig. 2Follow-up image data of the 63-year-old female. a and b AP and lateral images of the hip joint before operation; c and d Postoperative X-ray images showed good reduction and fixation; e and f One year after the operation, the fracture healed well; g and h One and a half years after the operation, the internal fixation device was taken out. AP stands for anteroposterior
Fig. 3A 47-year-old male suffered from an extracapsular hip fracture and was treated using the PRDS technique. a and b Preoperative X-ray images of the injured hip; c and d During operation, PRDS technique was used for reduction; e and f Postoperative X-ray images showed that this fracture was well reduced and fixed; g and h Intra-operative X-ray images of the PRDS technique. PRDS stands for percutaneous reduction with double screwdrivers
Fig. 4A 61-year-old patient was successfully treated with the PRDS technique. a and b: Preoperative X-ray images of the injured hip; c and f Intra-operative images of the PRDS technique; d and e Postoperative X-ray images of the affected hip. PRDS stands for percutaneous reduction with double screwdrivers
Fig. 5A 73-year-old female was treated with the LOR technique. a and b Preoperative X-ray images of the injured hip; c and d Postoperative X-ray images; e: Clamp reduction was performed during operation; f Schematic diagram of the incisions. LOR stands for limited open reduction
Demographics of patients with extracapsular hip fractures
| Variable | PRDS group ( | LOR group ( | |
|---|---|---|---|
| Gender | 0.973 | ||
| male | 30 | 28 | |
| female | 36 | 34 | |
| Age (year) | 68 ± 16 | 66 ± 12 | 0.427 |
| BMI (kg/m2) | 23 ± 4 | 24 ± 3 | 0.114 |
| ASA score | 0.848 | ||
| grade I | 7 | 6 | |
| grade II | 30 | 24 | |
| grade III | 25 | 27 | |
| grade IV | 4 | 5 | |
| Evans-Jensen classification | 0.833 | ||
| type II | 5 | 3 | |
| type III | 20 | 16 | |
| type IV | 22 | 23 | |
| type V | 19 | 20 |
PRDS stands for percutaneous reduction with double screwdrivers, LOR stands for limited open reduction, BMI stands for body mass index, ASA stands for American society of anesthesiologists
Operation indexes and clinical effects of the PRDS and LOR technique
| Variable | PRDS group ( | LOR group ( | |
|---|---|---|---|
| Incision length (cm) | 8.4 ± 1.4 | 15.3 ± 3.0 | |
| Blood loss (ml) | 151 ± 26 | 319 ± 33 | |
| Fluoroscopic number (N.) | 14 ± 3 | 8 ± 2 | |
| Operation time (min) | 44 ± 9 | 73 ± 11 | |
| Inpatient time (d) | 6.2 ± 1.7 | 8.4 ± 2.2 | |
| Weight training time (d) | 4.5 ± 1.5 | 10.7 ± 1.8 | |
| Excellent rate of Harris score | 61/66 (92.4%) | 55/62 (88.7%) | 0.471 |
Postoperative complications of the PRDS and LOR technique
| Variable | PRDS group ( | LOR group ( | |
|---|---|---|---|
| Nonunion n(%) | 0 (0.0%) | 2 (3.2%) | - |
| Incision infection n(%) | 0(0.0%) | 2 (3.2%) | - |
| Sacral ulcer n(%) | 1(1.5%) | 5(8.1%) | 0.182 |
| Pneumonia n(%) | 3(4.5%) | 6(9.7%) | 0.430 |
| DVT n(%) | 3(4.5%) | 5(8.1%) | 0.648 |
DVT stands for deep vein thrombosis